Free Trial

Integrated Wealth Concepts LLC Raises Stock Position in Doximity, Inc. $DOCS

Doximity logo with Medical background

Key Points

  • Integrated Wealth Concepts LLC significantly increased its stake in Doximity, Inc. by 133.1%, now holding shares worth $1.81 million.
  • Doximity reported a quarterly earnings per share (EPS) of $0.36, surpassing the consensus estimate of $0.31, with a 15.2% year-over-year revenue increase.
  • As of now, 87.19% of Doximity's stock is held by institutional investors and hedge funds, indicating strong institutional interest in the company.
  • MarketBeat previews the top five stocks to own by October 1st.

Integrated Wealth Concepts LLC increased its position in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 133.1% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 31,187 shares of the company's stock after buying an additional 17,807 shares during the period. Integrated Wealth Concepts LLC's holdings in Doximity were worth $1,810,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. VSM Wealth Advisory LLC bought a new position in Doximity in the 1st quarter worth $29,000. Allworth Financial LP boosted its holdings in Doximity by 104.0% in the 1st quarter. Allworth Financial LP now owns 563 shares of the company's stock worth $32,000 after buying an additional 287 shares during the period. National Bank of Canada FI bought a new position in Doximity in the 1st quarter worth $33,000. Spire Wealth Management boosted its holdings in shares of Doximity by 73.2% during the 1st quarter. Spire Wealth Management now owns 615 shares of the company's stock valued at $36,000 after purchasing an additional 260 shares during the last quarter. Finally, Brooklyn Investment Group boosted its holdings in shares of Doximity by 70.7% during the 1st quarter. Brooklyn Investment Group now owns 746 shares of the company's stock valued at $43,000 after purchasing an additional 309 shares during the last quarter. Institutional investors own 87.19% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have commented on DOCS. Piper Sandler increased their price objective on shares of Doximity from $65.00 to $69.00 and gave the company an "overweight" rating in a report on Monday, August 11th. Zacks Research downgraded shares of Doximity from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. KeyCorp increased their price objective on shares of Doximity from $65.00 to $70.00 and gave the company an "overweight" rating in a report on Monday, July 14th. Truist Financial increased their price objective on shares of Doximity from $52.00 to $61.00 and gave the company a "hold" rating in a report on Thursday, July 17th. Finally, The Goldman Sachs Group set a $50.00 price objective on shares of Doximity and gave the company a "neutral" rating in a report on Wednesday, May 21st. Two investment analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $67.00.

Get Our Latest Stock Report on DOCS

Insider Buying and Selling

In related news, Director Regina M. Benjamin sold 5,000 shares of the stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $63.00, for a total value of $315,000.00. Following the sale, the director directly owned 16,618 shares of the company's stock, valued at $1,046,934. This represents a 23.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the completion of the sale, the director directly owned 16,618 shares in the company, valued at $948,721.62. This trade represents a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 32,000 shares of company stock valued at $1,929,380 in the last ninety days. 31.30% of the stock is owned by company insiders.

Doximity Trading Up 1.1%

Shares of NASDAQ:DOCS traded up $0.79 during trading on Friday, reaching $71.05. The company's stock had a trading volume of 1,374,597 shares, compared to its average volume of 2,224,099. Doximity, Inc. has a 12 month low of $38.30 and a 12 month high of $85.21. The firm's 50 day simple moving average is $63.60 and its two-hundred day simple moving average is $59.83. The stock has a market capitalization of $13.31 billion, a PE ratio of 71.05, a price-to-earnings-growth ratio of 4.10 and a beta of 1.37.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, beating analysts' consensus estimates of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same period in the prior year, the business posted $0.28 earnings per share. The company's revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Research analysts anticipate that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

About Doximity

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

See Also

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Should You Invest $1,000 in Doximity Right Now?

Before you consider Doximity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.

While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.